[Federal Register Volume 62, Number 89 (Thursday, May 8, 1997)]
[Notices]
[Pages 25209-25210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-11921]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the code of Federal
Regulations (CFR), this is notice that on December 18, 1996, Johnson
Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive,
West Deptford, NJ 08066, made application by renewal to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Difenoxin (9168)............................ I
Methylphenidate (1724)...................... II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Hydrocodone (9193).......................... II
Levorphanol (9220).......................... II
Meperidine (9230)........................... II
Methadone (9250)............................ II
Thebaine (9333)............................. II
[[Page 25210]]
Alfentanil (9737)........................... II
Sufentanil (9740)........................... II
Carfentanil (9743).......................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The firm plans to manufacture the listed controlled substances in
bulk to supply final dosage form manufacturers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application.
Any such comments or objections may be addressed, in quintuplicate,
to the Acting Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, DC 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than July 7, 1997.
Dated: March 31, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. 97-11921 Filed 5-7-97; 8:45 am]
BILLING CODE 4410-09-M